Insider Transactions Reported by 6 Insiders of OKYO Pharma Ltd

Symbol
OKYO on Nasdaq
Location
London, United Kingdom

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

OKYO Pharma Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gabriele M. Cerrone Director, 10%+ Owner $17,894,907 18 Mar 2026
Gary S. Jacob Chief Development Officer, Director $185,164 18 Mar 2026
John P. Brancaccio Director $25,005 15 Sep 2023
Bernard Denoyer Director 16 May 2022
Willy Jules Simon Director 16 May 2022
Keeren Shah Chief Financial Officer 16 May 2022

Recent Insider Transactions by Companies or Individuals for OKYO Pharma Ltd

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Gary S. Jacob OKYO COMMON STOCK 0 108,920 18 Mar 2026 Direct
Gabriele M. Cerrone OKYO COMMON STOCK 0 10,526,416 18 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.